Evidence map›Paper›PMID 20008138›Full record

ArticleThe American journal of pathology2010

Epithelial NF-kappaB enhances transmucosal fluid movement by altering tight junction protein composition after T cell activation.

Yueming Tang, Daniel R Clayburgh, Navdha Mittal, Tatiana Goretsky, Ramanarao Dirisina, Zheng Zhang, Michelle Kron, David Ivancic, Rebecca B Katzman, Gery Grimm and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 74 citations in OpenAlex.

  1. Review
  2. Article
  3. Pig-Derived ProbioticAnimals : an open access journal from MDPI · 2024
    Article
  4. Article
  5. Application of Intestinal Barrier Molecules in the Diagnosis of Acute Cellular Rejection After Intestinal Transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Loss of E-cadherin due to road dust PMEnvironmental science and pollution research international · 2021
    Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Yueming TangDivision of Gastroenterology, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.
Daniel R Clayburgh
Navdha Mittal
Tatiana Goretsky
Ramanarao Dirisina
Zheng Zhang
Michelle Kron
David Ivancic
Rebecca B Katzman
Gery Grimm
Goo Lee
Jonathan Fryer
Asma Nusrat
Jerrold R Turner
Terrence A Barrett
Northwestern University · USUniversity of Chicago · USEmory University · US

Funding

ZO-1-MEDIATED PROTEIN INTERACTIONS: REGULATORS AND INTEGRATORS OF DIVERSE EPITHELIAL FUNCTIONS IN HEALTH AND DISEASER01DK061931 · NIDDK · UNIVERSITY OF CHICAGO · PI JERROLD R. TURNER · 2001 to 2026
$15.0M
Therapeutic targeting of protein interactions to reverse MLCK1-mediated intestinal barrier loss and ameliorate disease.R01DK068271 · NIDDK · UNIVERSITY OF CHICAGO · PI JERROLD R. TURNER · 2005 to 2026
$11.3M
Regulation of intestinal epithelial barrier function by intercellular junction proteins in health and diseaseR01DK059888 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ASMA NUSRAT · 2001 to 2026
$10.5M
T CELL ACTIVATION AND CRYPT CELL APOPTOSISR01DK054778 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BARRETT, TERRENCE A. · 1999 to 2008
$3.0M
GENERATION AND MAINTENANCE EFFECTOR T CELLS IN INTESTINER01DK047073 · NIDDK · NORTHWESTERN UNIVERSITY · PI BARRETT, TERRENCE A. · 1999 to 2003
$1.1M
Permeability Changes in Small Bowel Allograft RejectionR21DK072544 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI FRYER, JONATHAN P · 2005 to 2006
$274k
NIDDK NIH HHS DK59888NIDDK NIH HHS R01 DK047073NIDDK NIH HHS R01 DK054778NIDDK NIH HHS R01 DK059888NIDDK NIH HHS R01 DK061931NIDDK NIH HHS R01 DK068271NIDDK NIH HHS R01DK-47073NIDDK NIH HHS R01DK-54778NIDDK NIH HHS R01DK61931NIDDK NIH HHS R01DK68271NIDDK NIH HHS R21 DK072544NIDDK NIH HHS R21DK072544
6 · The paper itself

Abstract

In inflammatory bowel disease (IBD), aberrant activation of innate and adaptive immune responses enhances mucosal permeability through mechanisms not completely understood. To examine the role of epithelial nuclear factor (NF-kappaB) in IBD-induced enhanced permeability, epithelial-specific IkappaBalpha mutant (NF-kappaB super repressor) transgenic (TG) mice were generated. NF-kB activation was inhibited in TG mice, relative to wild-type mice, following T cell-mediated immune cell activation using an anti-CD3 monoclonal antibody. Furthermore, epithelial NF-kappaB super repressor protein inhibited diarrhea and blocked changes in transepithelial resistance and transmucosal flux of alexa350 (0.35 kDa) and dextran3000 (3 kDa). In vivo perfusion loop studies in TG mice revealed reversed net water secretion and reduced lumenal flux of different molecular probes (bovine serum albumin, alexa350, and dextran3000). Cell-imaging and immunoblotting of low-density, detergent-insoluble membrane fractions confirmed that tight junction proteins (occludin, claudin-1 and zona occludens-1) are internalized through an NF-kappaB-dependent pathway. Taken together, these data suggest that IBD-associated diarrhea results from NF-kappaB-mediated tight junction protein internalization and increased paracellular permeability. Thus, reduction of epithelial NF-kappaB activation in IBD may repair defects in epithelial barrier function, reduce diarrhea, and limit protein (eg, serum albumin) losses. Epithelial NF-kappaB activation induced by mucosal T cells, therefore, actively plays a role in opening paracellular spaces to promote transmucosal fluid effux into the intestinal lumen.

Indexed as

AnimalsDiarrheaEpithelial CellsHumansI-kappa B ProteinsIntestinal MucosaIntestinesLymphocyte ActivationMacromolecular SubstancesMembrane ProteinsMiceMice, TransgenicMucous MembraneMutationNF-kappa BNF-KappaB Inhibitor alphaI-kappa B ProteinsMacromolecular SubstancesMembrane ProteinsNF-kappa BNF-KappaB Inhibitor alphaNFKBIA protein, humanNfkbia protein, mouse

Identifiers

PMID20008138
PMCPMC2797878
OpenAlexW2135480784

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.